EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Succinate Dehydrogenase in Lung Cancer: from Molecular Mechanisms to Clinical Implications

Yali Du, Lulu He, Yi Guo, Yuchen Zhang, Jianping He

OncoTargets and Therapy · 2026-10 · Volume 19 · 1-16

DOI: 10.2147/ott.s629223 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift OncoTargets and Therapy, 2026-10. Verfasst von Yali Du und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

epithelial-mesenchymal transitionlung cancermetabolic reprogrammingpseudohypoxiasuccinate dehydrogenase

Autor:innen und Institutionen

  • Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.
  • Division of Internal Medicine, Institute of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.

Zitieren

APA

Du, Y., He, L., Guo, Y., Zhang, Y., & He, J. (2026). Succinate Dehydrogenase in Lung Cancer: from Molecular Mechanisms to Clinical Implications. OncoTargets and Therapy, Volume 19, 1-16. https://doi.org/10.2147/ott.s629223

Vancouver

Du Y, He L, Guo Y, Zhang Y, He J. Succinate Dehydrogenase in Lung Cancer: from Molecular Mechanisms to Clinical Implications. OncoTargets and Therapy. 2026;Volume 19:1-16. doi:10.2147/ott.s629223

BibTeX
@article{Du2026,
  author = {Du, Yali and He, Lulu and Guo, Yi and Zhang, Yuchen and He, Jianping},
  title = {Succinate Dehydrogenase in Lung Cancer: from Molecular Mechanisms to Clinical Implications},
  journal = {OncoTargets and Therapy},
  year = {2026},
  volume = {Volume 19},
  pages = {1--16},
  doi = {10.2147/ott.s629223}
}
Kostenlos starten →